Boston Scientific Corporation vs Medtronic PLC — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Medtronic PLC trades at $90.5 (market cap $116.07B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays a 3.18% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | MDT | |
|---|---|---|
Market Cap | $74.19B | $116.07B |
Sector | Health | Health |
52-Week High | $108.14 | $105.35 |
52-Week Low | $42.63 | $73.75 |
Enterprise Value | $86.27B | $134.82B |
Dividend Yield | — | 3.18% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →